These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 31162908)

  • 1. Medical Treatment and Prevention of Urinary Stone Disease.
    Spradling K; Ganesan C; Conti S
    Urol Clin North Am; 2022 May; 49(2):335-344. PubMed ID: 35428438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health.
    Scales CD; Tasian GE; Schwaderer AL; Goldfarb DS; Star RA; Kirkali Z
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1305-1312. PubMed ID: 26964844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statement of the II meeting of the expert council on prevention of urinary stone disease (02.12.2022, Moscow)].
    Urologiia; 2023 Sep; (4):150. PubMed ID: 37850296
    [No Abstract]   [Full Text] [Related]  

  • 4. Leveraging behavioral modification technology for the prevention of kidney stones.
    Aksenov LI; Streeper NM; Scales CD
    Curr Opin Urol; 2024 Jan; 34(1):14-19. PubMed ID: 37962162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial.
    Pasilan RM; Pawar N; Alawieh R; Hiremath S; Teakell J
    Kidney Med; 2023 Dec; 5(12):100739. PubMed ID: 37954501
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazides for the prevention of kidney stone recurrence: are they really effective?
    Buso H; Butera E; Tramontano D; Bandini G;
    Intern Emerg Med; 2024 Aug; 19(5):1459-1461. PubMed ID: 38429589
    [No Abstract]   [Full Text] [Related]  

  • 7. [The place of mineral water in the metaphylaxis of urolithiasis].
    Saenko VS; Gazimiev MA; Pesegov SV
    Urologiia; 2016 Apr; (2 Suppl 2):87-94. PubMed ID: 28247650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrence prevention for urinary stone disease. Part II.The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation (continuation)].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2018 Dec; (6):131-138. PubMed ID: 30742392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of drinking and dietary factors in effective dissolution therapy and recurrence prevention of uric acid kidney stones].
    Saenko VS; Pesegov SV; Frolova EA
    Urologiia; 2019 Jun; (2):113-118. PubMed ID: 31162912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence prevention in patients with urinary tract stone disease.
    Tiselius HG
    ScientificWorldJournal; 2004 Jan; 4():35-41. PubMed ID: 14755100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2019 Jun; (2):88-96. PubMed ID: 31162908
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.